OClawVPS.com
Pfizer Venture Investments
Edit

Pfizer Venture Investments

https://www.pfizer.com/
Last activity: 09.04.2026
Active
Breakthroughs That Change Patients' Lives: Pfizer is a leading research-based biopharmaceutical company. We apply science and our global resources to deliver innovative therapies that extend and significantly improve lives. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time.To learn more, visit www.pfizer.com. For additional information on our guidelines, please visit http://www.pfizer.com/community-guidelines Beware of scams from individuals, organizations and Internet sites claiming to represent Pfizer in recruitment activities. A formal Pfizer recruitment process is required for all authorized positions posted by Pfizer prior to issuing an offer of employment. This Pfizer process includes an interview and never requires payment or fees from job applicants. If you receive a suspicious email message or phone call about recruiting on behalf of Pfizer, do not provide any personal information or pay any fees. Interested candidates should apply to current openings through this Pfizer website. Pfizer accepts no responsibility for any costs or charges incurred as a result of fraudulent activity.
Followers
5.41M
Portfolio
3
Mentions
1.78K
Location: United States, New York
Employees: 10001+

Portfolio 3

DateNameWebsiteTotal RaisedLocation
25.02.2026Sciwindsciwindbio.com$565MChina
15.10.2025Mission Th...missiontherapeutics.com$191.92MUnited Kin...
24.07.2023CellCentri...cellcentric.com$171MUnited Kin...

Mentions in press and media 1777

DateTitleDescription
09.04.2026AI-Powered Pharma Manufacturing Signals Scalable Efficiency, Long-Term Cost AdvantagesAs regulatory demands intensify and production environments become more complex, pharmaceutical manufacturers are shifting beyond traditional quality assurance systems toward a new operational model: integrating artificial intelligence dire...
07.04.2026Corporate Vision and Trade Confrontation: The Shifting U.S. Economic NarrativeMotorola Solutions CEO Greg Brown earns top honors, lauded for transforming the company into a global public safety and security technology leader. His strategic vision and operational prowess drove exceptional growth and innovation. Meanwh...
06.04.2026Biotech Firm Gets a New Leader New chief chosen-
02.04.2026Trump unveils 100% tariff on some patented drugs on ‘Liberation Day’ anniversaryGetting your Trinity Audio player ready... By WYATTE GRANTHAM-PHILIPS, AP Business Writer NEW YORK (AP) — President Donald Trump signed an executive order Thursday that could slap long-threatened pharmaceutical tariffs of up to 100% on some...
02.04.2026BioNTech to close vaccine manufacturing plant in Singapore by 2027Listen 3 min New: You can now listen to articles. This audio is generated by an AI tool. SINGAPORE: BioNTech will shutter its vaccine manufacturing plant in Singapore by the end of February next year, the German biotechnology firm said on T...
02.04.2026Trump administration prepares up to 100% pharmaceutical tariffs on some imported drugsThe Trump administration is preparing to impose new tariffs on branded drugs from pharmaceutical companies that have not struck landmark deals with the president to lower their U.S. drug prices, CNBC has learned. The Trump administration is...
30.03.2026Harbour BioMed Reports Full Year 2025 Financial Results: Sustained Global Collaboration Underpins Long-Term GrowthCAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, March 30, 2026 /PRNewswire/ -- Harbour BioMed ("HBM" or the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of...
29.03.2026Origin Secures $30M to Revolutionize Global Employee Benefits with AIOrigin, an AI-powered enterprise benefits platform, just secured $30 million in Series A+ funding, pushing its total capital beyond $50 million. The company targets global employee benefits, an area rife with inefficiency and fragmentation....
28.03.2026Origin: $30 Million Series A+ Raised For AI-Powered Benefits Intelligence PlatformOrigin, an AI-powered enterprise benefits platform, announced it has raised $30 million in a Series A+ funding round, bringing its total funding to over $50 million within the past year as it targets inefficiencies in global employee benefi...
23.03.2026Pfizer to seek FDA approval for Lyme disease vaccine candidate despite trial missPfizer said it will seek regulatory approval for a Lyme disease vaccine candidate despite failing a late-stage trial. Pfizer said not enough people contracted Lyme disease to be confident in the results, but cited “strong efficacy” for its ...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In